A Clinical Comparison of Pivmecillinam plus Pivampicillin (Miraxid) and a Triple Tetracycline Combination (Deteclo) in Respiratory Infections Treated in General Practice

  title={A Clinical Comparison of Pivmecillinam plus Pivampicillin (Miraxid) and a Triple Tetracycline Combination (Deteclo) in Respiratory Infections Treated in General Practice},
  author={J M Beatson and B. T. Marsh and D. J. Talbot},
  journal={Journal of International Medical Research},
  pages={197 - 202}
Seven-day courses of either pivmecillinam 200 mg plus pivampicillin 250 mg (Miraxid) or a combination of tetracycline hydrochloride, Chlortetracycline hydrochloride and demeclocycline hydrochloride (Deteclo) 300 mg, both given twice daily, were compared in a multicentre general practice study in 408 patients with symptoms of upper or lower respiratory tract infection. Patients were stratified into four diagnostic groups: sinusitis, otitis media, throat infections, and acute bronchitis and… 
6 Citations

Tables from this paper

A Comparative Study of Miraxid (Pivmecillinam plus Pivampicillin) and Augmentin (Amoxycillin plus Clavulanic Acid) in the Treatment of Lower Respiratory Tract Infections in General Practice
This single blind multicentre general practice study comparing twice-daily Miraxid with 3 times daily Augmentin demonstrated that both treatments were equally effective clinically and equally well tolerated.
WITHDRAWN: Antibiotics for acute maxillary sinusitis in adults.
Background Sinusitis is one of the most common diagnoses among adults in ambulatory care, accounting for 15% to 21% of all adult outpatient antibiotic prescriptions. However, the role of antibiotics
Antibiotics for acute maxillary sinusitis in adults.
There is moderate evidence that antibiotics provide a small benefit for clinical outcomes in immunocompetent primary care patients with uncomplicated acute sinusitis, and the clinical benefit was small.
Antibiotics for acute maxillary sinusitis.
For acute maxillary sinusitis confirmed radiographically or by aspiration, current evidence is limited but supports penicillin or amoxicillin for 7 to 14 days, and Clinicians should weigh the moderate benefits of antibiotic treatment against the potential for adverse effects.
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.
PCV is effective in reducing the incidence of IPD from all serotypes but exerts a greater effect in reducing VT IPD, and there are still uncertainties about the definition of this outcome.


A comparison of pivmecillinam/pivampicillin and co-trimoxazole in hospitalized patients with acute exacerbations of chronic bronchitis.
Patients with acute exacerbations of chronic bronchitis were randomly allocated a ten-day course of either pivmecillinam/pivampicillin or co-trimoxazole, and both treatments were equally effective clinically and in their ability to eradicate pus from sputum.
Comparison of Ampicillin and Tetracycline in Chronic Bronchitis
Ampicillin has greater activity against Haemophilus influenzae than benzylpenicillin and effective blood levels can be obtained after oral administration, suggesting that ampicillin may be valuable in the treatment of chronic bronchitis.
In Vivo Synergy Between 6β-Amidinopenicillanic Acid Derivatives and Other Antibiotics
Both an oral and a parenteral form of a 6β-amidinopenicillanic acid derivative were found to have appreciable activity against gram-negative bacteria and poor activity against gram-positive bacteria
Properties of the penicillin-binding proteins of Escherichia coli K12,.
  • B. Spratt
  • Biology, Computer Science
    European journal of biochemistry
  • 1977
It is shown that penicillins bind to all six proteins but that at least some cephalosporins fail to bind, or bind very slowly, to proteins 2, 5 and 6, although they bind to the other proteins.
Miraxid in chronic bronchitis, a comparison with pivampicillin
  • Proceedings of 13th International Congress of Chemotherapy, Vienna, 28th August-Znd September,
  • 1983
Single - blind comparison of Miraxid and co - trimoxazole in patients with sinusitis and otitis
  • 1983